SII will be granted the license for selling and distributing the MVA-BN mpox vaccine in India. Credit: Pormezz/Shutterstock. Bavarian Nordic has signed a licence and
GSK has acquired exclusive global rights to progress the clinical development and commercialisation of GSK’227. Credit: MAXSHOT.PL/Shutterstock. GlaxoSmithKline (GSK)’s B7-H3-targeted antibody-drug conjugate (ADC), GSK’227 has
Nemluvio is intended for individuals aged 12 years and above with moderate-to-severe atopic dermatitis. Credit: Kmpzzz/Shutterstock. The US Food and Drug Administration (FDA) has approved
Lilly has filed marketing applications for the therapy in Crohn’s disease treatment across various worldwide markets. Credit: JHVEPhoto/Shutterstock. The European Medicines Agency’s (EMA) Committee for
The deal includes a $200m cash payment from AbbVie at closing, subject to standard adjustments, alongside potential interim funding payments. Credit: © AbbVie Inc. All
AGAMREE is used in treating Duchenne muscular dystrophy in individuals aged four years and above. Credit: AnnGaysorn/Shutterstock. China’s National Medical Products Administration (NMPA) has approved
XENLETA is intended to treat community-acquired bacterial pneumonia in the adult population. Credit: New Africa/Shutterstock. Meitheal Pharmaceuticals has gained exclusive US commercial rights for a
The two candidates protect against influenza subtypes A and B and coronavirus (SARS-CoV-2) infections. Credit: fizkes/Shutterstock. Sanofi has announced that its two combination vaccine candidates,
TransCon CNP, one of the therapies in the agreement, is currently in clinical development for achondroplasia. Credit: Louis Reed on Unsplash. Er-Kim has extended its
The partnership focuses on the discovery and validation of new therapeutics that target fibrotic diseases and osteoarthritis. Credit: murat photographer/Shutterstock. Relation has announced two strategic